Study directory

Schizophrenia studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
4306studies shown
Showing 1,201-1,212 of 4,306
Drug study icon
CompletedNCT04972227

Safety study of Safety and Pharmacokinetics of CY6463 in schizophrenia

This study is completed in the United States. It is testing Safety and Pharmacokinetics of CY6463 for schizophrenia.

Multiple locations, including Long Beach
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugA study involving a medication or substance.From 18 Years to 50 Years
Countries
United States
Sponsor
Tisento Therapeutics
Condition
Schizophrenia
Drug study icon
CompletedNCT02411695

Safety study of Brexpiprazole (OPC- 34712) in schizophrenia

This study is completed in the United States. It is testing Brexpiprazole (OPC- 34712) for schizophrenia.

Multiple locations, including Little Rock
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 13 Years to 17 Years
Countries
United States
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
Schizophrenia
Drug study icon
CompletedNCT00690274

Study to Demonstrate Cognitive Enhancing Effects of BF2.649

This summary needs review. Please check the official study record and contact the research team for details.

In Dallas
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 55 Years
Countries
United States
Sponsor
University of Texas Southwestern Medical Center
Condition
Schizophrenia
Drug study icon
CompletedNCT03397134

Roluperidone for schizophrenia

This study is completed in the United States, in Bulgaria, in Poland, .... It is testing roluperidone for schizophrenia.

Multiple locations, including Rogers
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 55 Years
Countries
United States, Bulgaria, Poland, ...
Sponsor
Minerva Neurosciences
Condition
Schizophrenia
Drug study icon
TerminatedNCT02261519

Safety & Efficacy of NaBen® for schizophrenia

This study was terminated in the United States. It is testing safety & Efficacy of NaBen® for schizophrenia.

In Pasadena
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 45 Years
Countries
United States
Sponsor
SyneuRx International (Taiwan) Corp
Condition
Schizophrenia
Drug study icon
CompletedNCT03160521

Risperidone for schizophrenia

This study is completed in the United States and in Ukraine. It is testing risperidone for schizophrenia.

Multiple locations, including Rogers
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States, Ukraine
Sponsor
Rovi Pharmaceuticals Laboratories
Condition
Schizophrenia
Drug study icon
CompletedNCT03870880

Risperidone ISM® for schizophrenia

This study is completed in the United States and in Ukraine. It is testing Risperidone ISM® for schizophrenia.

Multiple locations, including Rogers
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States, Ukraine
Sponsor
Rovi Pharmaceuticals Laboratories
Condition
Schizophrenia
Drug study icon
TerminatedNCT05182476

Safety study of efficacy, Safety, and Tolerability of Luvadaxistat in schizophrenia

This study was terminated in the United States, in Bulgaria, in Czechia, .... It is testing efficacy, Safety, and Tolerability of Luvadaxistat for schizophrenia.

Multiple locations, including Phoenix
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 50 Years
Countries
United States, Bulgaria, Czechia, ...
Sponsor
Neurocrine Biosciences
Condition
Schizophrenia
Drug study icon
TerminatedNCT05654870

Efficacy, Safety, and Tolerability of Valbenazine for schizophrenia

This study was terminated in the United States. It is testing efficacy, Safety, and Tolerability of Valbenazine for schizophrenia.

Multiple locations, including San Jose
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugOver 13 Years
Countries
United States
Sponsor
Neurocrine Biosciences
Condition
Schizophrenia
Drug study icon
CompletedNCT03201757

Long-term Safety, Tolerability, and Durability of Treatment Effect of ALKS 3831

This study is completed in the United States, in the United Kingdom, in Austria, .... It focuses on Schizophrenia.

Multiple locations, including Little Rock
Why is this study shown?

This study is directly about Schizophrenia.

Schizophrenia, BipolarityDrugFrom 16 Years to 70 Years
Countries
United States, United Kingdom, Austria, ...
Sponsor
Alkermes, Inc.
Condition
Schizophrenia, Bipolarity
Drug study icon
CompletedNCT03503318

TV-46000 for schizophrenia

This study is completed in the United States and in Bulgaria. It is testing TV-46000 for schizophrenia.

Multiple locations, including Little Rock
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 13 Years to 65 Years
Countries
United States, Bulgaria
Sponsor
Teva Branded Pharmaceutical Products R&D, Inc.
Condition
Schizophrenia
Drug study icon
CompletedNCT04010305

Sub-Lingual Dexmedetomidine in Agitation Associated With Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Little Rock
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
BioXcel Therapeutics Inc
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.